Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Haemonetics Cell Saver Elite/Elite+ Autotransfusion System

K-Number: K162423 · 2017-01-03

Decision Date2017-01-03
Product CodeCAC
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

Haemonetics Cell Saver Elite/Elite+ Autotransfusion System is a medical device manufactured by Haemonetics Corporation. It received FDA 510(k) clearance on 2017-01-03 under approval number K162423. The device is classified under product code CAC. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Haemonetics Cell Saver Elite/Elite+ Autotransfusion System?

Haemonetics Cell Saver Elite/Elite+ Autotransfusion System is a medical device that received FDA 510(k) clearance on 2017-01-03. It is manufactured by Haemonetics Corporation. The 510(k) number is K162423.

When was Haemonetics Cell Saver Elite/Elite+ Autotransfusion System approved by the FDA?

Haemonetics Cell Saver Elite/Elite+ Autotransfusion System received FDA 510(k) clearance on 2017-01-03, under approval number K162423.

What company makes Haemonetics Cell Saver Elite/Elite+ Autotransfusion System?

Haemonetics Cell Saver Elite/Elite+ Autotransfusion System is manufactured by Haemonetics Corporation.

What is the FDA product code for Haemonetics Cell Saver Elite/Elite+ Autotransfusion System?

The FDA product code for Haemonetics Cell Saver Elite/Elite+ Autotransfusion System is CAC.

Related Clinical Trials

Other Devices by Haemonetics Corporation

View all 7 devices →

Related Devices (Code: CAC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.